Evidence map›Paper›PMID 23646299›Full record

ArticleAsian Pacific journal of tropical biomedicine2013

A study of in vitro antibacterial activity of lanthanides complexes with a tetradentate Schiff base ligand.

Waleed Mahmoud Al Momani, Ziyad Ahmed Taha, Abdulaziz Mahmoud Ajlouni, Qasem Mohammad Abu Shaqra, Muaz Al Zouby

Abstract read
In one paragraph

Article in Asian Pacific journal of tropical biomedicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Waleed Mahmoud Al MomaniDepartment of Allied Medical Sciences, Al Balqa' Applied University, P.O. Box 19117, Al-Salt, Jordan.
Ziyad Ahmed Taha
Abdulaziz Mahmoud Ajlouni
Qasem Mohammad Abu Shaqra
Muaz Al Zouby

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo establish the antibacterial activity of lanthanides complexes with a tetradentate Schiff base ligand L.

methods(N, N'-bis (1-naphthaldimine)-o-phenylenediamine) was prepared from the condensation of 2-hydroxy-1-naphthaldehyde with o-phenylenediamine in a molar ratio of 2:1. The antimicrobial activity of the resultant Ln (III) complexes was investigated using agar well diffusion and micro-broth dilution techniques; the latter was used to establish the minimum inhibitory concentrations for each compound investigated.

resultsMost of Ln (III) complexes were found to exhibit antibacterial activities against a number of pathogenic bacteria with MICs ranging between 1.95-250.00 µg/mL. Staphylococcus aureus was the most susceptible bacterial species to [LaL(NO3)2(H2O)](NO3) complex while Shigella dysenteriae and Escherichia coli required a relatively higher MIC (250 µg/mL). The complexes La (III) and Pr (III) were effective inhibitors against Staphylococcus aureus, whereas Sm (III) complex was effective against Serratia marcescens. On the other hand, Gd (III), La (III) and Nd (III) were found to be more potent inhibitors against Pseudomonas aeruginosa than two of commonly used antibiotics. The remaining Ln (III) complexes showed no remarkable activity as compared to the two standard drugs used.

conclusionsTetradentate Schiff base ligand L and its complexes could be a potential antibacterial compounds after further investigation.

Indexed as

Anti-Bacterial AgentsBacteriaDisk Diffusion Antimicrobial TestsLanthanoid Series ElementsLigandsMicrobial Sensitivity TestsSchiff BasesAnti-Bacterial AgentsLanthanoid Series ElementsLigandsSchiff BasesAntimicrobialBiomoleculesOrganicsSynthetic ligands

Identifiers

PMID23646299
PMCPMC3642445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.